NCT07352969: A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
- State
- Under way
- Phase
- Phase 2
- People
- 352 taking part
- Started
- 5 Feb 2026
- Primary completion
- 27 Mar 2029
- Arms
- IBI3016 dose 4, IBI3016 dose 1, IBI3016 dose 2, IBI3016 dose 3, IBI3016 dose 5
- Results
- None posted
- 20 Jan 2026: Trial registered
- 5 Feb 2026: Trial started